APA

Jiang X., Pissaloux D., De La Fouchardiere C., Desseigne F., Wang Q., Attignon V., Fondrevelle M., De La Fouchardiere A., Perol M., Cassier P., Seigne C., Perol D., Ray-Coquard I., Meeus P., Fayette J., Flechon A., Le Cesne A., Penel N., Tredan O. & Blay J. (20160722). The sum of gains and losses of genes encoding the protein tyrosine kinase targets predicts response to multi-kinase inhibitor treatment: Characterization, validation, and prognostic value. : Oncotarget.

Chicago

Jiang Xiaojun, Pissaloux Daniel, De La Fouchardiere Christelle, Desseigne Françoise, Wang Qing, Attignon Valery, Fondrevelle Marie-Eve, De La Fouchardiere Arnaud, Perol Maurice, Cassier Philippe, Seigne Christelle, Perol David, Ray-Coquard Isabelle, Meeus Pierre, Fayette Jerome, Flechon Aude, Le Cesne Axel, Penel Nicolas, Tredan Olivier and Blay Jean-Yves. 20160722. The sum of gains and losses of genes encoding the protein tyrosine kinase targets predicts response to multi-kinase inhibitor treatment: Characterization, validation, and prognostic value. : Oncotarget.

Harvard

Jiang X., Pissaloux D., De La Fouchardiere C., Desseigne F., Wang Q., Attignon V., Fondrevelle M., De La Fouchardiere A., Perol M., Cassier P., Seigne C., Perol D., Ray-Coquard I., Meeus P., Fayette J., Flechon A., Le Cesne A., Penel N., Tredan O. and Blay J. (20160722). The sum of gains and losses of genes encoding the protein tyrosine kinase targets predicts response to multi-kinase inhibitor treatment: Characterization, validation, and prognostic value. : Oncotarget.

MLA

Jiang Xiaojun, Pissaloux Daniel, De La Fouchardiere Christelle, Desseigne Françoise, Wang Qing, Attignon Valery, Fondrevelle Marie-Eve, De La Fouchardiere Arnaud, Perol Maurice, Cassier Philippe, Seigne Christelle, Perol David, Ray-Coquard Isabelle, Meeus Pierre, Fayette Jerome, Flechon Aude, Le Cesne Axel, Penel Nicolas, Tredan Olivier and Blay Jean-Yves. The sum of gains and losses of genes encoding the protein tyrosine kinase targets predicts response to multi-kinase inhibitor treatment: Characterization, validation, and prognostic value. : Oncotarget. 20160722.